Post

Lokavant introduces AI-powered feasibility software designed to optimise trials

US-based clinical trial software company Lokavant has launched Spectrum, a feasibility software solution designed to optimise studies. The AI-powered offering is …

Amber Implants reports positive initial results for spinal device

Netherlands-based Amber Implants has completed enrolment in its first-in-human trial evaluating the VCFix spinal system for the treatment of vertebral …

UK clinical trial sector must address prolonged timelines, say experts

Following a 2023 review of the UK clinical trial landscape, Lord James O’Shaughnessy, the former health minister highlighted major change …

DCTs no longer? Decentralised solutions in post-pandemic clinical trials

Aside from shining a light on the complexity of drug development and increased efforts in drug repurposing and de novo …

MDI Therapeutics doses first participants in Phase I SSc-ILD study

MDI Therapeutics has dosed the first participants in a Phase I study to support the development of a potential treatment …